000			01730 a2200457 4500
005			20250516202810.0
264		0	_c20150107
008			201501s 0 0 eng d
022			_a1873-5126
024	7		_a10.1016/j.parkreldis.2014.02.008 _2doi
040			_aNLM _beng _cNLM
100	1		_aThornton, Emma
245	0	0	_aThe NK1 receptor antagonist N-acetyl-L-tryptophan reduces dyskinesia in a hemi-parkinsonian rodent model. _h[electronic resource]
260			_bParkinsonism & related disorders _cMay 2014
300			_a508-13 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdrenergic Agents _xtoxicity
650	0	4	_aAnalysis of Variance
650	0	4	_aAnimals
650	0	4	_aAntiparkinson Agents _xadverse effects
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDyskinesia, Drug-Induced _xdrug therapy
650	0	4	_aFunctional Laterality _xdrug effects
650	0	4	_aLevodopa _xadverse effects
650	0	4	_aMale
650	0	4	_aMedial Forebrain Bundle _xinjuries
650	0	4	_aMotor Activity _xdrug effects
650	0	4	_aOxidopamine _xtoxicity
650	0	4	_aParkinsonian Disorders _xchemically induced
650	0	4	_aProto-Oncogene Proteins c-fos _xmetabolism
650	0	4	_aRats
650	0	4	_aRats, Sprague-Dawley
650	0	4	_aTime Factors
650	0	4	_aTryptophan _xanalogs & derivatives
650	0	4	_aTyrosine 3-Monooxygenase _xmetabolism
700	1		_aHassall, Mark Macquarie
700	1		_aCorrigan, Frances
700	1		_aVink, Robert
773	0		_tParkinsonism & related disorders _gvol. 20 _gno. 5 _gp. 508-13
856	4	0	_uhttps://doi.org/10.1016/j.parkreldis.2014.02.008 _zAvailable from publisher's website
999			_c23647838 _d23647838